IDXX | tickerfilter.com

Fundamental analysis

56%

Profitability 81%

Dept financing 25%

Liquidity 5%

Performance 52%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.59%

1 Month

3.34%

3 Months

3.64%

6 Months

-3.09%

1 Year

-14.12%

2 Year

-11.36%

Key data

Stock price

$433.99

P/E Ratio

38.13

DAY RANGE

$427.70 - $440.26

EPS

$10.77

52 WEEK RANGE

$356.14 - $548.88

52 WEEK CHANGE

-$11.93

MARKET CAP

33.854 B

YIELD

N/A

SHARES OUTSTANDING

82.306 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-01-2025

BETA

0.89

PUBLIC FLOAT

AVERAGE 10 VOLUME

$918,330

AVERAGE 30 VOLUME

$1,095,890

Company detail

CEO: Jonathan J. Mazelsky
Region: US
Website: idexx.com
Employees: 10,800
IPO year: 1991

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.

IDXX - IDEXX LABORATORIES INC /DE